Suppr超能文献

玻璃体腔注射曲安奈德联合光动力疗法治疗视网膜血管瘤样增生时血管通道的重塑

Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy.

作者信息

Bottoni Ferdinando, Romano Mary, Massacesi Amedeo, Bergamini Fulvio

机构信息

Department of Ophthalmology, San Giuseppe Hospital, Milan, Italy.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2006 Nov;244(11):1528-33. doi: 10.1007/s00417-006-0311-9. Epub 2006 Apr 12.

Abstract

BACKGROUND

The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT).

METHODS

Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later.

RESULTS

Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible.

CONCLUSIONS

Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.

摘要

背景

目的是描述玻璃体内注射曲安奈德(TA)及随后的光动力疗法(PDT)治疗II期视网膜血管瘤样增生(RAP)时血管通道的重塑情况。

方法

通过动态数字荧光素和吲哚菁绿血管造影记录3例连续患者(3只眼)继发于年龄相关性黄斑变性的II期RAP。所有患眼均接受玻璃体内注射TA(4mg,0.1ml),随后在5 - 10天后进行PDT治疗。

结果

吲哚菁绿血管造影(ICGA)显示治疗后三个RAP的血管结构完全重塑。治疗前将大部分血流从原来的小动脉分流至视网膜内新生血管复合体的供血视网膜动脉,治疗后恢复正常外观。随着RAP闭合,血流再次通过原来的视网膜小动脉,与RAP的连接不再可见。

结论

II期RAP是难以治疗的病变。玻璃体内TA和PDT联合使用可实现血管病变的真正重塑。这一发现证实了目前正在进行的随机临床试验的必要性,以评估这种联合治疗在湿性年龄相关性黄斑变性中的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验